Clinical trial
Continuous Glucose Monitoring Self-Monitored Blood Glucose Type 2 Therapy Matrix Definition
NCT01390610
Study timeline
Study start (unknown)2011-06-01Date precision: month
Registry last updated2015-11-26
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Diabetes Mellitus, Type 2unresolved
Diabetic Blood Glucose Monitoringunresolved
Interventions
Sponsors & collaborators
HealthPartners Institutelead sponsor
Abbott Diabetes Carecollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01390610 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.